Elsevier

Journal of Clinical Anesthesia

Volume 28, February 2016, Pages 36-40
Journal of Clinical Anesthesia

Editorial
Proposed mechanisms for association between opioid usage and cancer recurrence after surgery,☆☆

https://doi.org/10.1016/j.jclinane.2015.05.010Get rights and content

Introduction

Cancer remains one of the most prevalent and burdensome diseases on the modern health care landscape. Although significant success has been made toward effective medical and surgical treatment, cancer pain management presents a unique and continuing challenge. Recent epidemiological evidence has suggested that the selected anesthetic and analgesic management modalities for operative, postoperative, and long-term pain control appear to be associated with increased recurrence of certain malignancies [1], [2], [3], [4], [5], [6], [7], [8]. Several hypotheses to explain these clinical observations have been formulated and substantiated by basic science research. However, a lack of well-designed, prospective clinical trials precludes the dominance of one hypothesis over the other. There also exists the possibility of multiple near-simultaneous mechanisms being responsible for the finding.

Amelioration of cancer pain is typically achieved through the use of potent opioid analgesics. A 2007 review of pain management suggested that concerns about opioid abuse have led to the undertreatment of pain with opioid by “opioid-phobic” physicians [9]. Numerous practice guidelines have been established that stress the importance of individualized treatment of pain with both opioid and nonopioid analgesics. Rigorous adherence to these guidelines can yield significant pain relief [10], [11], [12]. With both chronic and cancer-related pain, dose escalation typically occurs in an effort to achieve a favorable balance of effective analgesia and opioid-related adverse effects [13]. Opioid analgesic use in cancer patients during the perioperative period is largely based on their presurgical opioid requirement. However, this common practice may need to be reexamined based on recent publications describing an association between opioid usage and cancer recurrence after excision of the primary tumor. We hypothesize that the immediate use of opioids in the perioperative period could act to suppress activity of natural killer cells (NK cells), whereas the long-term use of opioids in patients who develop persistent pain states may act to directly promote tumor growth.

Section snippets

Preliminary clinical studies examining the effect of opioid analgesia on cancer recurrence rates after surgery

Use of regional anesthesia decreases the requirement for postoperative opioid analgesics [14]. For example, Irish researchers found that surgery for breast cancer performed with paravertebral blockade using only levobupivicaine was associated with a 94% disease-free survival at both 24 and 36 months compared with 82% and 77% at the same time points in a similar surgical patient population not receiving regional anesthesia (P = .012) [2]. The use of paravertebral blocks for breast surgery

Potential mechanisms for association between opioid analgesics and cancer recurrences after surgery

A leading hypothesis for the apparent association between opioids and cancer recurrence rates is that chronic μ-opioid receptor (MOR) agonism results in direct stimulation of neoplastic cells and associated cellular pathways essential to tumor cell growth and metastatic spread. Stimulation of MORs has been found to promote the growth of existing tumors but not the growth of new tumors in rodents [28]. μ-Opioid receptors have been identified on the cellular surface of malignant tissue [29].

Conclusion

Basic science research and retrospective clinical studies have provided growing evidence of an association between postsurgical cancer recurrence and the perioperative use of opioid analgesics. It is likely that multiple pathways are responsible for this observation including the suppression of NK cells with immediate opioid administration and direct stimulation of neoplastic pathways with more prolonged opioid use. Although direct stimulation of neoplastic cellular growth pathways likely

References (60)

  • S. Kaseda et al.

    Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy

    Ann Thorac Surg

    (2000)
  • X. Bessa et al.

    Laparoscopic-assisted vs. open colectomy for colorectal cancer: influence on neoplastic cell mobilization

    J Gastrointest Surg

    (2001)
  • J.I. Yamashita et al.

    Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination

    J Thorac Cardiovasc Surg

    (2000)
  • J. Nguyen et al.

    Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer

    Br J Anaesth

    (2014)
  • P.A. Singleton et al.

    Increased mu-opioid receptor expression in metastatic lung cancer

    Br J Anaesth

    (2014)
  • C.J. Nelson et al.

    Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation

    Brain Behav Immun

    (2000)
  • D.M. Hall et al.

    Opioid mediated effects on the immune system: sympathetic nervous system involvement

    J Neuroimmunol

    (1998)
  • G. Wei et al.

    Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?

    Biochem Pharmacol

    (2003)
  • J.P. Cata et al.

    Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer

    J Clin Anesth

    (2013)
  • A. O'Garra et al.

    Role of cytokines in determining T-lymphocyte function

    Curr Opin Immunol

    (1994)
  • A.K. Exadaktylos et al.

    Can anesthetic technique for primary breast cancer surgery affect recurrence or

    Anesthesiology

    (2006)
  • B. Biki et al.

    Anesthetic technique for radical prostatectomy surgery affects cancer recurrence

    Anesthesiology

    (2008)
  • G.S. de Oliveira et al.

    Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery

    Reg Anesth Pain Med

    (2011)
  • R. Christopherson et al.

    Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia

    Anesth Analg

    (2008)
  • F. Brennan et al.

    Pain management: a fundamental human right

    Anesth Analg

    (2007)
  • E. Green et al.

    Cancer-related pain management: a report of evidence-based recommendations to guide practice

    Clin J Pain

    (2010)
  • P.J. Cormie et al.

    Control of pain in adults with cancer: summary of SIGN guidelines

    BMJ

    (2008)
  • K. Azevedo Sao Leao Ferreira et al.

    The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?

    Support Care Cancer

    (2006)
  • I. Power et al.

    Regional anaesthesia and pain management

    Anaesthesia

    (2010)
  • Y. Shir et al.

    The effect of epidural versus general anesthesia on postoperative pain and analgesic requirements in patients undergoing radical prostatectomy

    Anesthesiology

    (1994)
  • Cited by (0)

    Disclosures: This study was not associated with any grants, sponsors, or funding (including National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or departmental or institutional funding). However, Dr White receives support for his academic activities from the White Mountain Institute, The Sea Ranch, CA. This study has not been published elsewhere and is not under consideration for publication in another journal.

    ☆☆

    This manuscript has been read and approved by the 2 authors.

    View full text